To evaluate the functions of ANT2 in cancer development or the possible utility of ANT2 downregulation for breast cancer therapy, therefore, ANT2-specific knockdown experiments were performed with human breast cancer cell lines. Here, SLC25A5 is linked to breast carcinoma.